AU2001251136A1 - Compositions and methods for promoting wound healing - Google Patents

Compositions and methods for promoting wound healing

Info

Publication number
AU2001251136A1
AU2001251136A1 AU2001251136A AU5113601A AU2001251136A1 AU 2001251136 A1 AU2001251136 A1 AU 2001251136A1 AU 2001251136 A AU2001251136 A AU 2001251136A AU 5113601 A AU5113601 A AU 5113601A AU 2001251136 A1 AU2001251136 A1 AU 2001251136A1
Authority
AU
Australia
Prior art keywords
compositions
methods
wound healing
promoting wound
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251136A
Inventor
Ian Askill
Martha K. Newell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Technology Corp
Original Assignee
University of Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Technology Corp filed Critical University of Technology Corp
Publication of AU2001251136A1 publication Critical patent/AU2001251136A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/905—Specially adapted for travel through blood circulatory system
AU2001251136A 2000-04-06 2001-03-30 Compositions and methods for promoting wound healing Abandoned AU2001251136A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19558000P 2000-04-06 2000-04-06
US60195580 2000-04-06
PCT/US2001/010245 WO2001076650A1 (en) 2000-04-06 2001-03-30 Compositions and methods for promoting wound healing

Publications (1)

Publication Number Publication Date
AU2001251136A1 true AU2001251136A1 (en) 2001-10-23

Family

ID=22721951

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251136A Abandoned AU2001251136A1 (en) 2000-04-06 2001-03-30 Compositions and methods for promoting wound healing

Country Status (6)

Country Link
US (1) US6582713B2 (en)
EP (1) EP1272231A1 (en)
JP (1) JP2003530156A (en)
AU (1) AU2001251136A1 (en)
CA (1) CA2402790A1 (en)
WO (1) WO2001076650A1 (en)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780425B1 (en) * 1994-02-04 2004-08-24 Stephen J. Smith Method for application and maintenance of medication on body tissue
US5762955A (en) 1994-02-04 1998-06-09 Smith; Stephen Jay Method for application and maintenance of medication on body tissue
US8801681B2 (en) 1995-09-05 2014-08-12 Argentum Medical, Llc Medical device
US6861570B1 (en) * 1997-09-22 2005-03-01 A. Bart Flick Multilayer conductive appliance having wound healing and analgesic properties
US5814094A (en) 1996-03-28 1998-09-29 Becker; Robert O. Iontopheretic system for stimulation of tissue healing and regeneration
US7214847B1 (en) 1997-09-22 2007-05-08 Argentum Medical, L.L.C. Multilayer conductive appliance having wound healing and analgesic properties
US6087549A (en) * 1997-09-22 2000-07-11 Argentum International Multilayer laminate wound dressing
US8455710B2 (en) 1997-09-22 2013-06-04 Argentum Medical, Llc Conductive wound dressings and methods of use
WO2001076650A1 (en) 2000-04-06 2001-10-18 University Technology Corporation Compositions and methods for promoting wound healing
EP1305049A4 (en) * 2000-07-27 2004-04-21 Medlogic Global Ltd Methods for treating burns on mammalian skin to reduce the risk of infection and to minimize fluid loss
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
US20030148924A1 (en) * 2002-07-09 2003-08-07 Tamar Tennenbaum Methods and pharmaceutical compositions of healing wounds
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
US20100129332A1 (en) * 2000-07-31 2010-05-27 Tamar Tennenbaum Methods and pharmaceutical compositions for healing wounds
EP1383540B1 (en) * 2000-07-31 2009-04-29 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
FR2826278B1 (en) * 2001-06-20 2005-03-25 Lipha USE OF ANTIDIABETIC AGENTS FOR MANUFACTURING A MEDICAMENT HAVING A HEALING EFFECT
DE60216453T2 (en) * 2001-06-20 2007-09-20 Merck Santé USE OF ANTI-DIABETICS FOR THE PREPARATION OF A TREATMENT-DRIVING MEDICAMENT
KR20030010135A (en) * 2001-07-25 2003-02-05 엘지.필립스 엘시디 주식회사 manufacturing method of a liquid crystal display
US7129300B2 (en) * 2001-07-31 2006-10-31 Tyco Healthcare Group Lp Bioabsorbable adhesive compounds and compositions
US20030185889A1 (en) * 2002-03-27 2003-10-02 Jixiong Yan Colloidal nanosilver solution and method for making the same
CA2503376C (en) * 2002-10-28 2011-02-08 Tyco Healthcare Group Lp Bioabsorbable adhesive compounds
CA2534816A1 (en) * 2003-06-12 2004-12-23 Evan Newell Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors
DK200301128A (en) * 2003-08-05 2005-02-06 Thomsen Joern Oddershede Grant Preparation
JP4668902B2 (en) 2003-08-07 2011-04-13 ヒーラー リミテッド Pharmaceutical composition and method for promoting wound healing
WO2005070126A2 (en) * 2004-01-08 2005-08-04 The Regents Of The University Of Colorado Methods and compositions for treating human diseases and wounds with ucp and fas inhibitors
US20050182443A1 (en) * 2004-02-18 2005-08-18 Closure Medical Corporation Adhesive-containing wound closure device and method
US7457667B2 (en) * 2004-02-19 2008-11-25 Silverleaf Medical Products, Inc. Current producing surface for a wound dressing
US7662176B2 (en) * 2004-02-19 2010-02-16 Vomaris Innovations, Inc. Footwear apparatus and methods of manufacture and use
US20060009099A1 (en) * 2004-07-12 2006-01-12 Closure Medical Corporation Adhesive-containing wound closure device and method
US8348971B2 (en) * 2004-08-27 2013-01-08 Accessclosure, Inc. Apparatus and methods for facilitating hemostasis within a vascular puncture
US9707252B2 (en) 2005-02-09 2017-07-18 Covidien Lp Synthetic sealants
DE102005007920B4 (en) * 2005-02-10 2011-05-05 Aesculap Ag Flexible adhesive composition and its use
US20100100124A1 (en) * 2005-05-05 2010-04-22 Tyco Healthcare Group Lp Bioabsorbable surgical composition
US8044234B2 (en) * 2005-05-05 2011-10-25 Tyco Healthcare Group Lp Bioabsorbable surgical composition
US20090177226A1 (en) * 2005-05-05 2009-07-09 Jon Reinprecht Bioabsorbable Surgical Compositions
NZ566083A (en) * 2005-08-29 2012-11-30 Healor Ltd Methods and compositions for prevention and treatment of diabetic and aged skin
AU2006321911B2 (en) * 2005-12-06 2012-05-17 Covidien Lp Biocompatible surgical compositions
WO2007067624A2 (en) * 2005-12-06 2007-06-14 Tyco Healthcare Group Lp Bioabsorbable compounds and compositions containing them
CA2628598C (en) * 2005-12-06 2015-02-24 Tyco Healthcare Group Lp Bioabsorbable surgical composition
CA2628579C (en) * 2005-12-06 2014-07-08 Tyco Healthcare Group Lp Carbodiimide crosslinking of functionalized polethylene glycols
WO2007067623A2 (en) * 2005-12-06 2007-06-14 Tyco Healthcare Group Lp Biocompatible tissue sealants and adhesives
CA2629932C (en) * 2005-12-08 2014-07-08 Tyco Healthcare Group Lp Viscosity-reduced sprayable compositions
WO2007067764A2 (en) * 2005-12-08 2007-06-14 Tyco Healthcare Group Lp Biocompatible surgical compositions
EP1960447A4 (en) * 2005-12-08 2010-12-01 Tyco Healthcare Biocompatible surgical compositons
CA2573472A1 (en) * 2006-01-23 2007-07-23 Tyco Healthcare Group Lp Biodegradable hemostatic compositions
EP1991161B1 (en) 2006-02-22 2012-11-07 Tyco Healthcare Group, LP Biodegradable phosphoester polyamines
WO2007123610A2 (en) * 2006-03-22 2007-11-01 Pierce Instruments, Inc. Surgical end effector apparatus and method
WO2008006083A2 (en) 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
US7772306B2 (en) * 2006-07-18 2010-08-10 Glustitch, Inc. Cyanoacrylate compositions having increased stability under irradiation
FR2907683A1 (en) * 2006-10-27 2008-05-02 De Potter Philippe Viseux Medical composition, useful to prepare drug to regenerate wounded tissues and as bandage for healing wounds, comprises combination of two molecules comprising glucose and insulin
WO2008059541A1 (en) * 2006-11-17 2008-05-22 Metis S.R.L. Cosmetic product for the treatment of cicatricial tissues
US20080122582A1 (en) * 2006-11-29 2008-05-29 Texas Instruments Incorporated Location Based Portable Device Feature Disabler
US20110123476A1 (en) * 2007-05-24 2011-05-26 Mbiya Kapiamba Adhesive Formulations
US7858835B2 (en) * 2007-06-27 2010-12-28 Tyco Healthcare Group Lp Foam control for synthetic adhesive/sealant
US20100310542A1 (en) * 2007-07-30 2010-12-09 Healor Ltd. Pharmaceutical Compositions for treating wouds and related methods
US8500947B2 (en) 2007-11-15 2013-08-06 Covidien Lp Speeding cure rate of bioadhesives
US20090202609A1 (en) * 2008-01-06 2009-08-13 Keough Steven J Medical device with coating composition
US20090232904A1 (en) * 2008-03-13 2009-09-17 Stephen Quinto Homeopathic Skin Care Compositions and Uses Thereof
EP2303026B1 (en) 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US8173722B2 (en) * 2008-07-10 2012-05-08 Aesculap Ag Adhesive compositions for use in surgical therapy
KR101397912B1 (en) * 2009-02-24 2014-05-29 힐로 리미티드 Visfatin therapeutic agents for the treatment of acne and other conditions
US9192626B2 (en) * 2009-06-10 2015-11-24 American Silver, Llc Dental uses of silver hydrosol
WO2011083481A2 (en) 2010-01-11 2011-07-14 Healor Ltd. Method for treatment of inflammatory disease and disorder
CN104039369B (en) 2011-07-20 2017-06-16 布莱阿姆青年大学 Hydrophobicity plug draws Jining compound and the device comprising the compound
US10039285B2 (en) 2012-05-02 2018-08-07 Brigham Young University Ceragenin particulate materials and methods for making same
WO2013187899A1 (en) * 2012-06-14 2013-12-19 Ella Lindenbaum Compositions and methods for stimulating wound healing
CA2888241C (en) 2012-10-16 2020-12-29 Surmodics, Inc. Wound packing device and methods
US9445981B2 (en) * 2012-12-20 2016-09-20 Avon Products, Inc PLOD-2 stimulators and their use in the treatment of skin
WO2014107740A2 (en) 2013-01-07 2014-07-10 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
BR112015023747B1 (en) 2013-03-15 2023-04-18 Brigham Young University USE OF A STEROID CATION ANTIMICROBIAL COMPOUND (CSA) FOR THE PREPARATION OF A COMPOSITION TO TREAT, REDUCE, OR PREVENT ACUTE OR CHRONIC INFLAMMATION AND/OR ACUTE OR CHRONIC PAIN ASSOCIATED WITH A DISEASE OR A SYMPTOM OF DISEASE
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
USD824525S1 (en) 2014-09-25 2018-07-31 Ethicon Llc Release paper for wound treament devices
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
US10226550B2 (en) * 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10792024B2 (en) 2016-09-28 2020-10-06 Ethicon, Inc. Scaffolds with channels for joining layers of tissue at discrete points
US10687986B2 (en) 2016-09-29 2020-06-23 Ethicon, Inc. Methods and devices for skin closure
US10470934B2 (en) 2016-09-29 2019-11-12 Ethicon, Inc. Methods and devices for skin closure
USD848624S1 (en) 2016-09-29 2019-05-14 Ethicon, Inc. Release paper for wound treatment devices
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
US10470935B2 (en) 2017-03-23 2019-11-12 Ethicon, Inc. Skin closure systems and devices of improved flexibility and stretchability for bendable joints
US11504446B2 (en) 2017-04-25 2022-11-22 Ethicon, Inc. Skin closure devices with self-forming exudate drainage channels
KR20200091378A (en) * 2017-07-20 2020-07-30 고메즈-로페즈, 웬세슬라오 Formulations containing bio-compatible nano-structured biocatalyst materials for the treatment of wounds and infections
US10993708B2 (en) 2018-07-31 2021-05-04 Ethicon, Inc. Skin closure devices with interrupted closure

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3800792A (en) 1972-04-17 1974-04-02 Johnson & Johnson Laminated collagen film dressing
FR2504408B1 (en) 1981-04-24 1986-02-14 Couvreur Patrick PROCESS FOR THE PREPARATION OF SUBMICROSCOPIC PARTICLES, PARTICLES THUS OBTAINED AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US4528265A (en) 1982-05-11 1985-07-09 Becker Robert O Processes and products involving cell modification
US4708716A (en) 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
JPS6099182A (en) 1983-11-04 1985-06-03 Atsugi Chuo Kenkyusho Kk Metallic powder or carbon powder for mixing in cyanoacrylate and electrically conductive curable composition composed of cyanoacrylate and metallic powder or carbon powder for mixing in cyanoacrylate
US4847049A (en) 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
US5654267A (en) 1988-12-20 1997-08-05 La Jolla Cancer Research Center Cooperative combinations of ligands contained within a matrix
JP2820268B2 (en) * 1989-04-28 1998-11-05 久光製薬株式会社 Skin treatment material for transdermal administration
US5145679A (en) 1989-10-05 1992-09-08 Hinson Joan B Topical emollient for prevention and treatment of circulatory induced lesions
US5591709A (en) * 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
CA2153343A1 (en) 1993-01-11 1994-07-21 Valery Alexandrovich Dyatlov Small diameter nanocapsules, process for their preparation and applications thereof
US5328687A (en) 1993-03-31 1994-07-12 Tri-Point Medical L.P. Biocompatible monomer and polymer compositions
WO1996010374A1 (en) * 1994-10-03 1996-04-11 Otogen Corporation Differentially biodegradable biomedical implants
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
US5814094A (en) 1996-03-28 1998-09-29 Becker; Robert O. Iontopheretic system for stimulation of tissue healing and regeneration
US5817343A (en) 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
CN1246032A (en) 1997-01-10 2000-03-01 医疗逻辑综合公司 Cyanoacrylate compositions comprising antimicrobial agent
US5684042A (en) 1997-01-10 1997-11-04 Medlogic Global Corporation Cyanoacrylate compositions comprising an antimicrobial agent
US5785972A (en) 1997-01-10 1998-07-28 Tyler; Kathleen A. Colloidal silver, honey, and helichrysum oil antiseptic composition and method of application
WO1998030091A1 (en) 1997-01-10 1998-07-16 Medlogic Global Corporation Methods for treating non-suturable, superficial wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent
US6102205A (en) 1997-10-08 2000-08-15 Medlogic Global Corporation Prepolymer compositions comprising an antimicrobial agent
US5962010A (en) 1997-11-03 1999-10-05 Medlogic Global Corporation Methods and compositions for treating dermatoses
US6001345A (en) 1997-11-03 1999-12-14 Medlogic Global Corporation Application of cyanoacrylate/anti-microbial compositions to the peri-wound or peri-mucosal area
WO1999023150A1 (en) * 1997-11-03 1999-05-14 Medlogic Global Corporation Cyanoacrylate polymer compositions comprising an antimicrobial agent
WO1999022934A1 (en) * 1997-11-03 1999-05-14 Medlogic Global Corporation Prepolymer compositions comprising an antimicrobial agent
US6174919B1 (en) 1998-02-18 2001-01-16 Closure Medical Corporation Cyanoacrylate compositions with vinyl terminated ester groups
FR2775435B1 (en) 1998-02-27 2000-05-26 Bioalliance Pharma NANOPARTICLES COMPRISING AT LEAST ONE POLYMER AND AT LEAST ONE COMPOUND CAPABLE OF COMPLEXING ONE OR MORE ACTIVE INGREDIENTS
BR9910063A (en) 1998-04-30 2000-12-26 Closure Medical Corp Set to supply a medicine to a patient, and manufacture a package
WO2001076650A1 (en) 2000-04-06 2001-10-18 University Technology Corporation Compositions and methods for promoting wound healing

Also Published As

Publication number Publication date
JP2003530156A (en) 2003-10-14
CA2402790A1 (en) 2001-10-18
WO2001076650A1 (en) 2001-10-18
EP1272231A1 (en) 2003-01-08
US6582713B2 (en) 2003-06-24
US20020122787A1 (en) 2002-09-05

Similar Documents

Publication Publication Date Title
AU2001251136A1 (en) Compositions and methods for promoting wound healing
AU2001245437A1 (en) Lightweight methods and compositions for well treating
EP1157707B8 (en) Method and composition for deforming soft tissues
AU2002324737A1 (en) Anti-cancer and wound healing compounds
AU2001250875A1 (en) Anti-microbial and immunostimulating composition
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001219651A1 (en) Mulch composition and method
AU2001248742A1 (en) Compositions for promoting sleep
AU2001266926A1 (en) Hemostatic compositions, devices and methods
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
AU2001234782A1 (en) Compositions and methods for promoting healthy joints
AU5647601A (en) Hair treatment compositions
AU2001273972A1 (en) Hair treatment composition
AU2001233932A1 (en) Method and composition
AU3205801A (en) Method and composition for promoting hair growth
AU2003291456A1 (en) Methods for promoting wound healing and uses thereof
AU4090301A (en) Compression bandage
AU2002239775A1 (en) Chemical-library composition and method
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AU3321100A (en) Method and pharmaceutical composition for wound healing
AU2002312514A1 (en) Hoxd3 compositions ad methods for improved wound healing
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
AU2002223679A1 (en) Hair treatment composition
AU2001287674A1 (en) Hair treatment compositions
AUPR069500A0 (en) Tissue modification